# | Title | Journal | Year | Citations |
---|
1 | The Safety of Melatonin in Humans | Clinical Drug Investigation | 2016 | 320 |
2 | Pharmacology of Silymarin | Clinical Drug Investigation | 2002 | 259 |
3 | Armodafinil and Modafinil Have Substantially Different Pharmacokinetic Profiles Despite Having the Same Terminal Half-Lives | Clinical Drug Investigation | 2009 | 240 |
4 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review | Clinical Drug Investigation | 2018 | 226 |
5 | Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis | Clinical Drug Investigation | 2010 | 223 |
6 | Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee | Clinical Drug Investigation | 2010 | 202 |
7 | HairMax LaserComb® Laser Phototherapy Device in the Treatment of Male Androgenetic Alopecia | Clinical Drug Investigation | 2009 | 179 |
8 | Pharmacokinetic Profile of Liposome Bupivacaine Injection Following a Single Administration at the Surgical Site | Clinical Drug Investigation | 2013 | 169 |
9 | Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder | Clinical Drug Investigation | 2014 | 159 |
10 | Adverse Effects Associated with Non-opioid and Opioid Treatment in Patients with Chronic Pain | Clinical Drug Investigation | 2012 | 149 |
11 | Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia | Clinical Drug Investigation | 2020 | 148 |
12 | Depression during Pregnancy | Clinical Drug Investigation | 2004 | 137 |
13 | The PAIN Study: Paracetamol, Aspirin and Ibuprofen New Tolerability Study | Clinical Drug Investigation | 1999 | 126 |
14 | Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis | Clinical Drug Investigation | 2004 | 111 |
15 | Topical 5% Lidocaine (Lignocaine) Medicated Plaster Treatment for Post-Herpetic Neuralgia | Clinical Drug Investigation | 2009 | 110 |
16 | Acarbose | Clinical Drug Investigation | 2002 | 107 |
17 | Work, Classroom and Activity Impairment Instruments | Clinical Drug Investigation | 1996 | 104 |
18 | Economic Burden of Haematological Adverse Effects in Cancer Patients | Clinical Drug Investigation | 2007 | 103 |
19 | Pain Mechanisms in Patients with Chronic Pain | Clinical Drug Investigation | 2012 | 100 |
20 | Ginkgo biloba for Dementia | Clinical Drug Investigation | 1999 | 97 |
21 | Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease | Clinical Drug Investigation | 2000 | 96 |
22 | Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers | Clinical Drug Investigation | 1998 | 95 |
23 | Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder | Clinical Drug Investigation | 2011 | 93 |
24 | Methotrexate and Hepatic Toxicity in??Rheumatoid Arthritis and Psoriatic Arthritis | Clinical Drug Investigation | 2006 | 89 |
25 | Placebo-Controlled Evaluation of the Efficacy and Tolerability of Permixon® in Benign Prostatic Hyperplasia after Exclusion of Placebo Responders | Clinical Drug Investigation | 1995 | 87 |
26 | Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines | Clinical Drug Investigation | 1998 | 86 |
27 | Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H1-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis | Clinical Drug Investigation | 2001 | 86 |
28 | Overview of the Clinical Pharmacokinetics of Oxcarbazepine | Clinical Drug Investigation | 2004 | 86 |
29 | Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy | Clinical Drug Investigation | 2009 | 83 |
30 | Azithromycin for COVID-19: More Than Just an Antimicrobial? | Clinical Drug Investigation | 2020 | 83 |
31 | Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive | Clinical Drug Investigation | 2011 | 82 |
32 | Amlexanox for the Treatment of Recurrent Aphthous Ulcers | Clinical Drug Investigation | 2005 | 81 |
33 | A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec | Clinical Drug Investigation | 2013 | 81 |
34 | Pharmacokinetics and Biotransformation of Mirtazapine in Human Volunteers | Clinical Drug Investigation | 1998 | 79 |
35 | Treatment of Myasthenia Gravis | Clinical Drug Investigation | 2011 | 79 |
36 | Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant | Clinical Drug Investigation | 2013 | 78 |
37 | Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS | Clinical Drug Investigation | 2019 | 78 |
38 | Clinical Pharmacokinetics of Artemether and Lumefantrine (Riamet??) | Clinical Drug Investigation | 1999 | 77 |
39 | Stereoselective Disposition of Proton??Pump Inhibitors | Clinical Drug Investigation | 2008 | 77 |
40 | Tourette??s Syndrome and Role??of??Tetrabenazine | Clinical Drug Investigation | 2008 | 77 |
41 | High-Dose N-Acetylcysteine in??Patients with Exacerbations of??Chronic Obstructive Pulmonary Disease | Clinical Drug Investigation | 2005 | 76 |
42 | Sodium Oxybate: A Review of Its Use in Alcohol Withdrawal Syndrome and in the Maintenance of Abstinence in Alcohol Dependence | Clinical Drug Investigation | 2014 | 76 |
43 | A Randomised Comparison of the Effects of Nebivolol and Atenolol with and without Chlorthalidone on??the Sexual Function of Hypertensive Men | Clinical Drug Investigation | 2005 | 74 |
44 | Double-Blind Comparison of Escitalopram and Duloxetine in??the??Acute Treatment of Major??Depressive Disorder | Clinical Drug Investigation | 2007 | 74 |
45 | Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations | Clinical Drug Investigation | 2011 | 74 |
46 | Parenteral versus Oral Route Increases Paracetamol Efficacy | Clinical Drug Investigation | 1997 | 73 |
47 | Parecoxib Sodium does not Impair Platelet Function in Healthy Elderly and Non-Elderly Individuals | Clinical Drug Investigation | 2001 | 72 |
48 | Quality of Drug Prescribing in Elderly People in Nursing Homes and Special Care Units for Dementia | Clinical Drug Investigation | 2010 | 72 |
49 | Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study | Clinical Drug Investigation | 2013 | 72 |
50 | Effect of Clozapine-Quetiapine Combination Therapy on Weight and Glycaemic Control | Clinical Drug Investigation | 1999 | 71 |